Estimating the potential cost of a high dose immune tolerance induction (ITI) therapy relative to the cost of a combined therapy of a low dose ITI therapy with bypassing agent prophylaxis
G. Kenet, A. Oladapo*, J. D. Epstein, C. Thompson, A. Novack, D. J. Nugent
Research output: Contribution to journal › Article › peer-review
6Scopus
citations
Fingerprint
Dive into the research topics of 'Estimating the potential cost of a high dose immune tolerance induction (ITI) therapy relative to the cost of a combined therapy of a low dose ITI therapy with bypassing agent prophylaxis'. Together they form a unique fingerprint.